Overview
Wei Yang is a primary care provider, practicing in Internal Medicine in Alvin, Texas. Dr. Yang has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Yang is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MD Anderson
Dai Chihara is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Chihara is rated as an Elite provider by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Peripheral T-Cell Lymphoma, T-Cell Lymphoma, and Bone Marrow Aspiration.
Utmb Faculty Group Practice
Megan Berman is a primary care provider, practicing in Internal Medicine in Galveston, Texas. Dr. Berman is rated as an Advanced provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Deep Vein Thrombosis, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Embolism, Endoscopy, and Hemorrhoidectomy. Dr. Berman is currently accepting new patients.
Etsuko Aoki is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Aoki is rated as an Experienced provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Childhood Pancreatitis, Acute Lymphoblastic Leukemia (ALL), Chronic T-Cell Leukemia (CTCL), and Prolymphocytic Leukemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Yang isExperienced. Learn about Breast Cancer.
- EGFR Positive Lung CancerDr. Yang isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Yang isExperienced. Learn about Familial Colorectal Cancer.
- Hairy Cell Leukemia (HCL)Dr. Yang isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Lung AdenocarcinomaDr. Yang isExperienced. Learn about Lung Adenocarcinoma.